The global Schizophrenia Drug market is expected to reach USD 11.80 billion by 2030, at a CAGR of 3.3% during the forecast period 2022 to 2030. Schizophrenia is a mental condition in which people see reality improperly. Common symptoms include hallucinations, delusions, and profoundly disturbed thought and behaviour that interfere with daily functioning and can be devastating.